AvalehtSYK • NYSE
add
Stryker Corp
Viimane sulgemishind
338,38 $
Tänane vahemik
341,06 $ - 347,52 $
Aasta vahemik
319,32 $ - 404,87 $
Turuväärtus
131,49 mld USD
Keskmine maht
2,15 mln
P/E suhe
40,88
Dividendimäär
1,03%
Põhibörs
NYSE
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (USD) | dets 2025info | Y/Y muutus |
|---|---|---|
Käive | 7,17 mld | 11,42% |
Põhitegevusega seonduv kulu | 2,72 mld | 6,74% |
Puhastulu | 849,00 mln | 55,49% |
Puhaskasumimarginaal | 11,84 | 39,62% |
Puhaskasum aktsia kohta | 4,47 | 11,47% |
EBITDA | 2,27 mld | 18,67% |
Tõhus maksumäär | 50,21% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (USD) | dets 2025info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 4,10 mld | −8,75% |
Kogu vara | 47,84 mld | 11,34% |
Kõik kohustused | 25,42 mld | 13,82% |
Kogu omakapital | 22,42 mld | — |
Emiteeritud aktsiate arv | 382,69 mln | — |
Hinna ja väärtuse suhe P/B | 5,77 | — |
Varade tasuvus | 10,29% | — |
Kapitali tasuvus | 12,57% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (USD) | dets 2025info | Y/Y muutus |
|---|---|---|
Puhastulu | 849,00 mln | 55,49% |
Põhitegevuse rahakäive | 2,14 mld | 10,98% |
Investeeringute raha | −305,00 mln | −0,66% |
Finantseerimise raha | −1,09 mld | 39,07% |
Raha ja raha ekvivalentide muutus | 755,00 mln | 481,31% |
Tasuta rahavoog | 1,73 mld | 57,90% |
Teave
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
Tegevjuht
Asutatud
1941
Veebisait
Töötajate arv
56 000